[A case of biclonal myeloma (IgG-IgA)]. 1976

M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009194 Myeloma Proteins Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA. M Components,Proteins, Myeloma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
February 1973, Revista clinica espanola,
M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
October 2020, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
February 2000, Internal medicine (Tokyo, Japan),
M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
November 2001, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
April 2009, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
January 1998, Ryoikibetsu shokogun shirizu,
M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
May 2000, Gan to kagaku ryoho. Cancer & chemotherapy,
M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
October 2013, Clinica chimica acta; international journal of clinical chemistry,
M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
December 2016, Journal of clinical and diagnostic research : JCDR,
M A Cagianelli, and A Lofaro, and F Messina, and R Parenti, and A Beati
April 1989, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!